Aier Eye Hospital Group Co Ltd
SZSE:300015
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9.13
19.09
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Aier Eye Hospital Group Co Ltd
Cost of Revenue
Aier Eye Hospital Group Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
Cost of Revenue
-¥10.3B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-24%
|
|
|
H
|
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
|
Cost of Revenue
-¥2.8B
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
Hengkang Medical Group Co Ltd
SZSE:002219
|
Cost of Revenue
-¥2.7B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-26%
|
|
|
X
|
XiAn International Medical Investment Co Ltd
SZSE:000516
|
Cost of Revenue
-¥4.5B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
-4%
|
|
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
Cost of Revenue
-¥2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
Cost of Revenue
-¥1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aier Eye Hospital Group Co Ltd
Glance View
Aier Eye Hospital Group Co., Ltd., founded in 2001 and headquartered in Changsha, China, has emerged as a leading player in the ophthalmology healthcare sector in Asia. Starting as a single eye clinic, it has grown exponentially to encompass a vast network of over 60 hospitals and numerous outpatient service centers across China and beyond. The company focuses on providing comprehensive eye care services, including cataract surgery, myopia treatment, and other advanced healthcare solutions, leveraging cutting-edge technology and innovative techniques. With a dedicated team of skilled specialists and a commitment to enhancing patient outcomes, Aier aims to address the increasing demand for vision care in a rapidly aging population, underpinned by a robust business model that merges quality healthcare delivery with strategic expansion. As an investor, Aier Eye Hospital presents a compelling opportunity in the burgeoning health sector. With healthcare spending expected to rise in China and globally, Aier's prominence in eye care positions it well to tap into this growing market. The company's commitment to research and development ensures continuous innovation and adaptation to emerging healthcare trends, setting it apart from traditional healthcare providers. Furthermore, Aier's expansion strategy, including potential international outreach, offers a promise of sustained growth. By investing in Aier, one is not just supporting a service provider but joining a forward-thinking healthcare institution that is poised to redefine eye care and generate significant returns.
See Also
What is Aier Eye Hospital Group Co Ltd's Cost of Revenue?
Cost of Revenue
-10.3B
CNY
Based on the financial report for Sep 30, 2024, Aier Eye Hospital Group Co Ltd's Cost of Revenue amounts to -10.3B CNY.
What is Aier Eye Hospital Group Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-24%
Over the last year, the Cost of Revenue growth was -9%. The average annual Cost of Revenue growth rates for Aier Eye Hospital Group Co Ltd have been -14% over the past three years , -15% over the past five years , and -24% over the past ten years .
You don't have any saved screeners yet
